Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment.
Journal of personalized medicine · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
biomarkersdiagnostic reassessmentneuroinflammationneuroplasticitypersonalized medicineprecision psychiatrypseudo-resistancesuicide risktreatment-resistant depression
Come citare questo studio
Davoud Amiri, Swetang J Shah, Lamberto Briziarelli, Sara Amiri, Barry Karlsson. (2026). Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment.. Journal of personalized medicine. DOI: 10.3390/jpm16090468
Consulta la pubblicazione originale ↗